stockstudiox / iStockphoto.com
27 March 2020Big PharmaRory O'Neill
Canada authorises compulsory licences for COVID-19 shortfalls
Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
30 April 2020 Foreign patents protecting COVID-19 treatments may stall efforts to protect citizens, says Mark Engelman of Hardwicke chambers.
Americas
26 October 2020 The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.
Big Pharma
21 April 2022 Nova Chemicals has asked Canada’s top court to revisit a historic patent damages award of CAD$645 million won by Dow Chemical at the country’s federal court of appeal.
Editor's picks
Editor's picks
Big Pharma
21 April 2022 Nova Chemicals has asked Canada’s top court to revisit a historic patent damages award of CAD$645 million won by Dow Chemical at the country’s federal court of appeal.
Americas
26 October 2020 The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.
Americas
30 April 2020 Foreign patents protecting COVID-19 treatments may stall efforts to protect citizens, says Mark Engelman of Hardwicke chambers.
Big Pharma
21 April 2022 Nova Chemicals has asked Canada’s top court to revisit a historic patent damages award of CAD$645 million won by Dow Chemical at the country’s federal court of appeal.
Americas
26 October 2020 The final version of guidelines issued by Canada’s federal drug price regulator last week has caused uproar among the pharma industry.
Americas
30 April 2020 Foreign patents protecting COVID-19 treatments may stall efforts to protect citizens, says Mark Engelman of Hardwicke chambers.